Filing Flows › Petmed Express (PETS) › Q4 FY25
Petmed Express (PETS) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Oct 14, 2025
Petmed Express (PETS) reported revenue of $50.8M for the fourth quarter fiscal 2025 (Q4 FY25), -24% from a year earlier and -2% from the quarter before. Operating margin was -11.9%, net loss $11.6M (22.9% of revenue).
Petmed Express, Q4 FY25: revenue $50.8M (-24% year over year), operating margin -11.9%, net loss $11.6M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $50.8M | -2% | -24% |
| Operating profit | −$6.0M | — | — |
| Net earnings | −$11.6M | — | — |
| Operating cash flow | $7.0M | — | -2% |
| Free cash flow | $4.6M | — | -21% |
What changed
Revenue was $50.8M in Q4 FY25, down 24% year over year and down 2% from the previous quarter.
Gross margin was 29.9%, up 1.2 points from a year earlier. Operating costs exceeded revenue by $6.0M, an operating margin of -11.9%. Operating expenses fell 7% while revenue fell 24%. The quarter ended with a net loss of $11.6M, wider than the previous quarter's $707K loss.
Operating cash flow was $7.0M (down 2% year over year). Non-cash charges added back $2.1M of depreciation and amortization and $593K of share-based compensation. Working capital and other items added $16.0M. Capital expenditures of $2.4M left free cash flow of $4.6M.
Questions
What was Petmed Express' revenue in the fourth quarter fiscal 2025?
Petmed Express (PETS) reported revenue of $50.8M for the fourth quarter fiscal 2025 (Q4 FY25), -24% from a year earlier and -2% from the quarter before.
Was Petmed Express profitable in the fourth quarter fiscal 2025?
Operating loss was $6.0M (-11.9% of revenue) and net loss $11.6M.
Source: Petmed Express 10-K on SEC EDGAR.